— Know what they know.
Not Investment Advice

PULM NASDAQ

Pulmatrix, Inc.
1W: -2.5% 1M: +6.8% 3M: -9.2% YTD: -30.5% 1Y: -68.0% 3Y: -21.9% 5Y: -90.0%
$1.57
+0.03 (+1.95%)
 
Weekly Expected Move ±9.9%
$1 $1 $2 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 47 · $5.7M mcap · 4M float · 1.23% daily turnover · Short 33% of daily vol

Balance Sheet Trends

Total Assets
$4M -58.4% ▼
5Y CAGR: -35.9%
Total Liabilities
$329K -67.0% ▼
5Y CAGR: -53.4%
Shareholders Equity
$4M -57.4% ▼
5Y CAGR: -30.3%
Cash & Investments
$4M -57.1% ▼
5Y CAGR: -33.6%
Total Debt
$0 +0.0% ▲
Net Debt
-$4M +57.1% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$54M$36M$19M$10M$4M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$54M$36M$19M$10M$4M
Net Receivables$67K$1M$928K$0$0
Inventory$0$153K$0$0$0
Other Current Assets$0$166K$372K$180K$41K
Total Current Assets$55M$38M$21M$10M$4M
Property, Plant & Equip.$2M$945K$11M$0$0
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$2M$1M$1M$10K$10K
Other Non-Current Assets$0$389K$176K$13K$0
Total Non-Current Assets$4M$3M$13M$23K$10K
Total Assets$59M$41M$34M$10M$4M
— Liabilities —
Accounts Payable$839K$1M$2M$809K$272K
Short-Term Debt$0$0$0$0$0
Deferred Revenue$939K$1M$618K$0$0
Other Current Liabilities$182K$508K$877K$71K$57K
Total Current Liabilities$4M$5M$4M$929K$329K
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$67K$0
Total Non-Current Liabilities$7M$5M$12M$67K$0
Total Liabilities$11M$10M$16M$996K$329K
— Equity —
Common Stock$0$0$0$0$0
Retained Earnings-$255M-$273M-$288M-$297M-$302M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$47M$31M$18M$9M$4M
Total Liabilities & Equity$59M$41M$34M$10M$4M
— Key Metrics —
Total Debt$2M$857K$9M$0$0
Net Debt-$52M-$35M-$10M-$10M-$4M
Total Investments$2M$1M$1M$10K$10K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms